Erythropoietin-associated hypertensive posterior leukoencephalopathy.

Abstract

Human recombinant erythropoietin is used to treat chronic anemia in patients with end-stage renal failure. Erythropoietin causes hypertension, and hypertensive encephalopathy has been associated with its use. We describe six dialysis-dependent, chronic renal failure patients who developed hypertension, headache, and seizures while on erythropoietin. Four of the six patients had posterior white matter changes on neuroimaging. The encephalopathy was managed by prompt antihypertensive and anticonvulsant treatment and by discontinuation of erythropoietin. Hypertensive posterior leukoencephalopathy is associated with erythropoietin use.

• Authors: N Delanty, C Vaughan, S Frucht, P Stubgen
• Journal: Neurology (Neurology) Vol. 49 Issue 3 Pg. 686-9 (Sep 1997) ISSN: 0028-3878 [Print] United States
• PMID: 9305323 (Publication Type: Case Reports, Journal Article)

Chemical References

• Anticonvulsants
• Recombinant Proteins
• Erythropoietin

Topics

• Adult
• Anemia (drug therapy, etiology)
• Anticonvulsants (therapeutic use)
• Brain Diseases (chemically induced, diagnosis, etiology, prevention & control)
• Child
• Drug Administration Schedule
• Erythropoietin (administration & dosage, adverse effects, therapeutic use)
• Humans
• Hypertension (chemically induced, complications, prevention & control)
• Kidney Failure, Chronic (complications, drug therapy)
• Magnetic Resonance Imaging
• Middle Aged
• Recombinant Proteins